Actinium Pharmaceuticals to Showcase ATNM-400 at 2025 SABCS with New Data on Cancer Treatment Actinium Pharmaceuticals is set to present new preclinical data on its lead therapy, ATNM-400, during the 2025 San Antonio Breast Cancer Symposium, focusing on HER2 and hormone-resistant breast cancer treatments.

Actinium Pharmaceuticals to Showcase ATNM-400 at 2025 SABCS with New Data on Cancer Treatment #United_States #San_Antonio #SABCS #Actinium #ATNM-400

Actinium Pharmaceuticals Announces Participation in Virtual Fireside Chat Conference Actinium Pharmaceuticals, known for its innovative cancer therapies, will engage in a Fireside Chat conference, discussing advancements and strategies in targeted radiotherapies.

Actinium Pharmaceuticals Announces Participation in Virtual Fireside Chat Conference #USA #New_York #oncology #Actinium #ATNM-400

Actinium's ATNM-400 Shows Promise Against Lung Cancer, Outperforming Leading EGFR Mutant Therapies Actinium Pharmaceuticals presents groundbreaking data on ATNM-400, showing it outperforms current EGFR mutant therapies in lung cancer, showcasing its potential in future treatments.

Actinium's ATNM-400 Shows Promise Against Lung Cancer, Outperforming Leading EGFR Mutant Therapies #USA #New_York #Actinium #ATNM-400 #Osimertinib

Actinium Pharmaceuticals Showcases Groundbreaking Efficacy of ATNM-400 for Prostate Cancer at Targeted Radiopharmaceuticals Summit Actinium Pharmaceuticals unveiled impressive data on ATNM-400’s potential against resistant prostate cancer models, outperforming current therapies at a major summit.

Actinium Pharmaceuticals Showcases Groundbreaking Efficacy of ATNM-400 for Prostate Cancer at Targeted Radiopharmaceuticals Summit #USA #San_Diego #Prostate_Cancer #Actinium #ATNM-400

Actinium's ATNM-400: A Game Changer in Prostate Cancer Treatment with Enhanced Efficacy Actinium Pharmaceuticals' ATNM-400 showcases superior efficacy against prostate cancer, outperforming existing treatments and overcoming resistance in clinical settings.

Actinium's ATNM-400: A Game Changer in Prostate Cancer Treatment with Enhanced Efficacy #United_States #New_Orleans #Prostate_Cancer #Actinium #ATNM-400

😯💡 #Revelation!

7 January 1939, #Actinium 227

7 January 1943, #NikolaTesla ☠️ Room 3327, #NYC

7 January 2015, I experienced a Presidential #Dejavu in #Phoenix AZ

7 January 2021, Congress, #Pence certify #Biden election

Pomerantz Law Firm Notifies Investors of Class Action Lawsuit Against Actinium Pharmaceuticals, Inc. Pomerantz Law Firm has unveiled a class action lawsuit against Actinium Pharmaceuticals, urging affected investors to participate before deadlines approach.

Pomerantz Law Firm Notifies Investors of Class Action Lawsuit Against Actinium Pharmaceuticals, Inc. #USA #New_York #Class_Action #Pomerantz #Actinium

Investors Alert: Actinium Pharmaceuticals Faces Class Action Lawsuit for Securities Fraud Allegations Actinium Pharmaceuticals, Inc. is currently facing a class action lawsuit regarding securities law violations, affecting investors. Act quickly to learn more.

Investors Alert: Actinium Pharmaceuticals Faces Class Action Lawsuit for Securities Fraud Allegations #United_States #New_York #securities_lawsuit #Actinium #ATNM

Actinium Pharmaceuticals Faces Class Action Lawsuit: Investors Urged to Act Swiftly Levi & Korsinsky LLP has alerted investors about a class action lawsuit against Actinium Pharmaceuticals. Affected shareholders should act by May 27, 2025.

Actinium Pharmaceuticals Faces Class Action Lawsuit: Investors Urged to Act Swiftly #USA #New_York #Levi_&_Korsinsky #Actinium #ATNM

Actinium Pharmaceuticals Showcases Actimab-A at AACR Meeting: A New Hope for AML Patients Actinium Pharmaceuticals presented Actimab-A at the AACR meeting, highlighting its potential as an effective treatment for acute myeloid leukemia (AML), showcasing mutation agnostic efficacy.

Actinium Pharmaceuticals Showcases Actimab-A at AACR Meeting: A New Hope for AML Patients #United_States #New_York #AML #Actinium #Actimab-A

Pomerantz Law Firm Issues Urgent Class Action Alert for Actinium Pharmaceuticals Investors The Pomerantz Law Firm alerts investors of a class action lawsuit against Actinium Pharmaceuticals, claiming securities fraud. Key deadlines are approaching.

Pomerantz Law Firm Issues Urgent Class Action Alert for Actinium Pharmaceuticals Investors #USA #New_York #Pomerantz_LLP #Actinium #ATNM

Original post on muenchen.social

Hi 👋

Wer mal wissen will was wir #Radiochemiker sonst so treiben außer an Brennstäben zu lutschen kann sich gerne mal das hier anschauen. Dabei geht es um #Nuklearmedizin und um den radioaktiven Stoff #Actinium

Auch wenn bei meinem AG Brennstoff keine Rolle spielt stellen wir ebenfalls das […]

Actinium Pharmaceuticals Faces Class Action Suit Over Alleged Securities Fraud Violations Investors in Actinium Pharmaceuticals, Inc. may join a class action lawsuit. Allegations cite various securities law violations that may have led to significant financial losses.

Actinium Pharmaceuticals Faces Class Action Suit Over Alleged Securities Fraud Violations #USA #New_York #Class_Action #Securities_Fraud #Actinium

Actinium Pharmaceuticals Reveals Game-Changing Prostate Cancer Treatment and Plans for 2025 Actinium Pharmaceuticals announces its novel non-PSMA prostate cancer radiotherapy, ATNM-400, along with an ambitious clinical pipeline for 2025, signaling a commitment to innovative cancer treatments.

Actinium Pharmaceuticals Reveals Game-Changing Prostate Cancer Treatment and Plans for 2025 #USA #New_York #Prostate_Cancer #Actinium #ATNM-400

Actinium Pharmaceuticals Partners with Memorial Sloan Kettering to Boost Actimab-A Clinical Advancement Actinium Pharmaceuticals and Memorial Sloan Kettering enter a collaboration to enhance Actimab-A's treatment efficacy for AML patients, targeting innovative therapies.

Actinium Pharmaceuticals Partners with Memorial Sloan Kettering to Boost Actimab-A Clinical Advancement #United_States #New_York #AML #Actinium #Actimab-A

Actinium Pharmaceuticals Launches Pioneering Trial for Actimab-A in AML With Novel Combination Therapy Actinium Pharmaceuticals initiates a groundbreaking clinical trial combining Actimab-A with Venetoclax and ASTX-727 for newly diagnosed AML patients, aiming for improved outcomes.

Actinium Pharmaceuticals Launches Pioneering Trial for Actimab-A in AML With Novel Combination Therapy #United_States #New_York #AML #Actinium #Actimab-A

An actinium atom wearing red boxing gloves and punching out a cancer cell

Actinium marks the beginning of the actinide series and has an eerie blue glow from its radioactivity. It has potential to be a cancer treatment because it decays into non-toxic bismuth instead of toxic lead.

#periodictable #elements #actinium #cancer #radiationtherapy #chemistry #education #art

How things have changed…25 years ago nuclear was dead. Now it’s proudly proclaimed. Even though the color has been altered for the banner, that cone vial contained a sample of actinium used in nuclear medicine. The sample glowed blue. #nuclear #actinium #fblockrocks #actinides #Chemsky #Bluesci